Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
API
Manufacturing
Teva to lay off 250 at for-sale API unit: report
The planned layoffs will be overseen by new leadership at TAPI, as its current CEO since late 2023, R. Ananthanarayanan, Ph.D., will retire in July.
Angus Liu
Jun 10, 2026 10:56am
Gilead, Yuhan expand partenership with $140M API contract
May 20, 2026 9:57am
Lilly’s U.S investment splurge continues with added $4.5B pledge
May 6, 2026 9:00am
Novartis plots NC ingredients plant for RNA meds and more
Apr 30, 2026 7:00am
AbbVie earmarks $380M for 2 new API plants
Feb 23, 2026 4:00pm
Fresenius, Phlow link to boost US epinephrine injection supply
Feb 9, 2026 11:08am